Loading...
Market
Will Ursula von der Leyen face formal legal action over COVID-19 vaccine contract transparency by end of 2024?
4
Resolution / Starting Odds
Yes • 50%
No • 50%
European Court of Justice or verified news reports
Story
EU's Second-Top Court Criticizes Ursula von der Leyen Over COVID-19 Vaccine Contract Transparency
Jul 17, 2024, 08:35 AM
The European Commission has been criticized by the EU's second-top court for not providing the public with sufficient access to COVID-19 vaccine purchase agreements. The court ruled that the Commission's decision to redact sections of the contracts contained irregularities, violating European law. The ruling highlights a lack of transparency in the Commission's handling of the vaccine deals with Big Pharma during the pandemic. Ursula von der Leyen, the President of the European Commission, was specifically mentioned as having violated European law by keeping the mRNA vaccine contracts excessively secret.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Very favorable • 25%
Somewhat favorable • 25%
Somewhat unfavorable • 25%
Very unfavorable • 25%
Release full contracts • 25%
Partially release contracts • 25%
Appeal the ruling • 25%
No action • 25%
Full disclosure of contracts • 25%
Partial disclosure of contracts • 25%
No disclosure of contracts • 25%
Appeal against ruling • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
